Trial · NCT01585129
Treatment Utility of Postpartum Antibiotics in Chorioamnionitis
NCT01585129, Phase 4, Terminated, Washington University School of Medicine; results first posted 2018-05-22
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Treatment Utility of Postpartum Antibiotics in Chorioamnionitis. Trials, record NCT01585129. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01585129
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Treatment Utility of Postpartum Antibiotics in Chorioamnionitis
- NCT number
- NCT01585129
- Status
- Terminated
- Phases
- Phase 4
- Enrollment
- 80 participants, actual
- Lead sponsor
- Washington University School of Medicine
- Conditions
- The Primary Outcome of This Study Will be the Rate of Endometritis
- Interventions
- Postpartum Antibiotics, No postpartum antibiotics
- First posted
- 2012-04-25
- Last updated
- 2018-06-19
- Results first posted
- 2018-05-22
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Paricipants With Endometritis | 7 days post-partum | Endometritis is defined as uterine infection and is diagnosed by maternal temp \> 38.0C on two occasions over a 4 hour period or any temp \> 39.0C after delivery \> 12 hours after delivery. Endometritis will be managed per currently accepted endometritis protocol - (Amp 2 gQ6, Gentamicin 5 mg/kg q24, Clindamycin 900 mg q8). |
| Secondary | Number of Participants With Infection-related Complications | 7 days post-partum | Infection related complications will include common complications attributed to infections there are not the primary outcome (endometritis). This will include infections of the wound and pelvic abscesses. |
| Secondary | Duration of Hospital Stay After Cesarean Delivery | Up to 7 Days | This is the duration of hospital stay (in days) after their cesarean delivery. |
Source ClinicalTrials.gov
Outcomes3
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Paricipants With Endometritis | 7 days post-partum | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Infection-related Complications | 7 days post-partum | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Duration of Hospital Stay After Cesarean Delivery | Up to 7 Days | days | MEAN |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Paricipants With Endometritis | Postpartum Antibiotics | 4 | Participants | ||
| Number of Paricipants With Endometritis | No Postpartum Antibiotics | 3 | Participants | ||
| Number of Participants With Infection-related Complications | Postpartum Antibiotics | 7 | Participants | ||
| Number of Participants With Infection-related Complications | No Postpartum Antibiotics | 2 | Participants | ||
| Duration of Hospital Stay After Cesarean Delivery | Postpartum Antibiotics | 4 | 95% Confidence Interval 4 to 4 | days | |
| Duration of Hospital Stay After Cesarean Delivery | No Postpartum Antibiotics | 4 | 95% Confidence Interval 3 to 4 | days |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Postpartum Antibiotics | 41 | |
| Overall Study | STARTED | No Postpartum Antibiotics | 39 | |
| Overall Study | COMPLETED | Postpartum Antibiotics | 41 | |
| Overall Study | COMPLETED | No Postpartum Antibiotics | 39 | |
| Overall Study | NOT COMPLETED | Postpartum Antibiotics | 0 | |
| Overall Study | NOT COMPLETED | No Postpartum Antibiotics | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Postpartum Antibiotics | ||
| Total, all-cause mortality | No Postpartum Antibiotics | ||
| Total, other adverse events | Postpartum Antibiotics | 0 | 41 |
| Total, other adverse events | No Postpartum Antibiotics | 0 | 39 |
| Total, serious adverse events | Postpartum Antibiotics | 0 | 41 |
| Total, serious adverse events | No Postpartum Antibiotics | 0 | 39 |
Source ClinicalTrials.gov
Papers7
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons3
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Postpartum Antibiotics vs No Postpartum Antibiotics: Number of Paricipants With Endometritis | Trial comparisons |
| Postpartum Antibiotics vs No Postpartum Antibiotics: Number of Participants With Infection-related Complications | Trial comparisons |
| Postpartum Antibiotics vs No Postpartum Antibiotics: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01585129
GET https://conductscience.org/api/trials/v1/NCT01585129/registered